Ignite Creation Date:
2024-05-05 @ 11:59 AM
Last Modification Date:
2024-10-26 @ 9:18 AM
Study NCT ID:
NCT00200252
Status:
COMPLETED
Last Update Posted:
2012-11-09
First Post:
2005-09-12
Brief Title:
Oxytocin Administration in the Third Stage of Labour - A Study of Appropriate Route and Dose
Sponsor:
Memorial University of Newfoundland
Organization:
Memorial University of Newfoundland
Study Overview
Official Title:
Intramuscular Versus Intravascular Oxytocin for the Third Stage of Labour
Status:
COMPLETED
Status Verified Date:
2012-11
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Mothers are given the medication oxytocin after birth to help the uterus womb contract and therefore reduce blood loss In Canada oxytocin is given either into the muscle of the thigh or into a vein However it is not known which route is betterThis study will test which dose and route of oxytocin is best in reducing blood loss following vaginal delivery
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None